AndroGel Cost in Arkansas (2026): Cash Price, Insurance, and Cheaper Alternatives

What Does AndroGel Actually Cost at Arkansas Pharmacies?

The average retail cash price for a 30-day supply of AndroGel 1.62% at Arkansas pharmacies sits near $510 in 2026. That figure reflects the manufacturer list price set by AbbVie and tracks closely with national averages reported by pharmacy benefit aggregators. Prices can shift by $20 to $40 between chains.

Walmart and Costco pharmacies in Little Rock, Fayetteville, and Jonesboro tend to price slightly below independent pharmacies. Using a free discount card from GoodRx or RxSaver can push the out-of-pocket cost down to roughly $430 to $470 at select locations, though these savings fluctuate weekly. The authorized generic version of testosterone gel 1.62%, manufactured by Teva, typically rings up between $350 and $420 cash, depending on the pharmacy.

A 2016 analysis in the Journal of Clinical Endocrinology & Metabolism found that out-of-pocket costs for testosterone replacement therapy (TRT) were a primary reason men discontinued treatment within the first year 1. That pattern still holds. When a 30-day supply costs more than a car payment, adherence suffers. Arkansas median household income ($52,528 per the U.S. Census) sits well below the national median, making cost a particularly acute barrier in this state.

The price gap between brand AndroGel and its alternatives is wide enough to change clinical decisions. A patient paying cash has several paths to a lower number, each with trade-offs worth examining.

Does Insurance Cover AndroGel in Arkansas?

Most commercial health plans sold in Arkansas, including Blue Cross Blue Shield of Arkansas, QualChoice, and Ambetter, include testosterone gel on their formularies. Coverage almost always requires prior authorization and two morning serum testosterone levels below 300 ng/dL, consistent with the Endocrine Society's 2018 clinical practice guideline for male hypogonadism 2.

Tier placement matters. Plans that list AndroGel on a specialty or non-preferred brand tier may assign copays of $75 to $150 per fill. Plans that place the authorized generic on a preferred brand tier often set copays between $25 and $50. Asking the prescriber to write for "testosterone gel 1.62%" rather than "AndroGel" gives the pharmacy flexibility to dispense the cheaper authorized generic when the plan allows therapeutic substitution.

Arkansas state employee health plans administered through the Employee Benefits Division (EBD) have historically covered testosterone gel with standard prior authorization. Members should verify current formulary placement through the EBD benefits portal or by calling the pharmacy benefit manager directly, as formulary tiers are updated annually.

For patients on Medicare Part D in Arkansas, testosterone gel falls under outpatient prescription drug coverage. The 2025 Inflation Reduction Act cap of $2,000 on annual out-of-pocket Part D spending means even patients in the coverage gap will see total yearly costs capped. That ceiling makes brand AndroGel more financially manageable for Medicare beneficiaries than it was before 2025 3.

Arkansas Medicaid Coverage for AndroGel

Arkansas Medicaid does cover AndroGel, but with a limited prior authorization requirement. The prescribing clinician must document a diagnosis of male hypogonadism (ICD-10 E29.1) supported by at least two morning serum total testosterone values below the laboratory reference range, typically below 264 to 300 ng/dL 2.

The Arkansas Department of Human Services Pharmacy Program uses a preferred drug list (PDL) that may favor the authorized generic over the brand. If the generic is preferred, the prescriber can still request brand AndroGel through a non-preferred prior authorization, though approval rates for non-preferred requests are lower. Medicaid recipients pay no more than the nominal copay ($1 to $3) once the authorization is approved.

Arkansas expanded Medicaid under the ARHOME program, extending coverage to adults earning up to 138% of the federal poverty level. That expansion means more men aged 30 to 65, the demographic most commonly diagnosed with hypogonadism, now have a coverage pathway for TRT that did not exist before 2014. The Testosterone Trials (T-Trials), a coordinated set of seven placebo-controlled studies enrolling 790 men aged 65 and older, confirmed that testosterone gel improved sexual function, physical activity, and mood over 12 months 4. Those findings support the clinical rationale that Medicaid reviewers weigh when evaluating prior authorization requests.

How the AbbVie Savings Card Works in Arkansas

AbbVie offers a copay savings card for commercially insured patients filling brand AndroGel. Eligible patients can pay as little as $0 per month, with the card covering up to a set dollar amount per fill (historically $75 to $100 off the copay). The card is not valid for patients on government insurance, including Medicaid, Medicare, TRICARE, or VA benefits.

Enrollment is free through the AndroGel website or by calling AbbVie's patient support line. The card is accepted at virtually all Arkansas retail pharmacies. Activation takes about 48 hours, and the pharmacist processes it as a secondary insurance at the point of sale.

There is a catch. AbbVie can modify or discontinue the savings card program at any time. Patients who rely on it should confirm that the program is still active before each refill cycle and should have a fallback plan, such as switching to the authorized generic or a compounded formulation, in case the card terms change.

"Manufacturer copay cards reduce the patient's immediate out-of-pocket cost, but they also insulate patients from the true cost of the drug and may discourage switching to lower-cost alternatives," noted a 2021 analysis in JAMA Internal Medicine 5. That observation applies directly here: the savings card makes brand AndroGel affordable month to month, but the patient's insurer still absorbs the higher wholesale cost, which eventually feeds back into premiums.

Is Compounded Testosterone Gel Legal in Arkansas?

Yes. Compounded testosterone gel is legal in Arkansas when dispensed by a pharmacy operating under a valid 503A compounding license. Section 503A of the Federal Food, Drug, and Cosmetic Act permits a licensed pharmacist to compound a medication in response to a valid individual patient prescription 6.

Arkansas has several 503A compounding pharmacies, including operations in Little Rock, Bentonville, and Hot Springs. A compounded testosterone gel formulation, typically at concentrations matching the 1% or 1.62% strengths of branded products, runs approximately $120 per month. That is 76% less than brand AndroGel's cash price.

The trade-off: compounded medications do not undergo the same FDA premarket review as commercially manufactured drugs. The FDA's 2012 guidance on pharmacy compounding, issued after the New England Compounding Center meningitis outbreak, tightened oversight of 503B outsourcing facilities but left 503A pharmacies under state board supervision 6. Patients choosing a compounded gel should verify that the pharmacy holds an active license with the Arkansas State Board of Pharmacy and ask whether the pharmacy conducts third-party potency and sterility testing.

Dr. Shalender Bhasin, professor of medicine at Harvard Medical School and lead investigator of multiple testosterone trials, has stated: "The decision between brand, generic, and compounded testosterone should weigh cost, consistency of drug delivery, and the patient's ability to adhere to therapy long-term" 7. For many Arkansas patients paying out of pocket, compounding tips that balance toward the $120-per-month option.

Can You Get AndroGel via Telehealth in Arkansas?

Arkansas permits telehealth prescribing of testosterone gel. The Arkansas State Medical Board allows clinicians to prescribe Schedule III controlled substances, including testosterone, via telemedicine as long as a valid provider-patient relationship is established. This can be done through a synchronous video visit under Arkansas telehealth rules (Act 203 of 2017, updated 2021).

Telehealth TRT clinics that serve Arkansas patients include HealthRX, Hone Health, and Defy Medical. These platforms typically bundle the initial consultation, lab orders (sent to a local Quest or Labcorp draw site), and ongoing monitoring into a monthly or quarterly subscription fee ranging from $100 to $200, separate from the cost of the medication itself.

One practical advantage of telehealth in Arkansas: access. Fourteen of Arkansas's 75 counties are classified as whole-county Health Professional Shortage Areas (HPSAs) by HRSA 8. A man in rural Izard or Searcy County may be 60 or more miles from an endocrinologist. Telehealth eliminates that drive.

The prescribing clinician still must order baseline labs (total testosterone, free testosterone, CBC, PSA, metabolic panel) and follow-up labs at 3 months, 6 months, and annually, per the Endocrine Society guideline 2. Telehealth does not reduce the clinical monitoring requirements. It reduces the geography problem.

Cheapest Ways to Get Testosterone Gel in Arkansas

The lowest-cost path depends on your insurance status. Here is a breakdown ranked by typical monthly out-of-pocket cost, from lowest to highest.

Commercially insured with AbbVie savings card: $0 to $25 per month. Requires a commercial plan that covers AndroGel or the authorized generic. Add the AbbVie copay card as secondary.

Compounded testosterone gel (503A pharmacy): approximately $120 per month. No insurance needed. Requires a prescription and a willing compounding pharmacy.

Authorized generic testosterone gel 1.62% (Teva): $350 to $420 cash, or $25 to $50 with insurance. Available at most chain pharmacies.

Arkansas Medicaid with prior authorization: $1 to $3 copay. Requires documented hypogonadism and PA approval.

Brand AndroGel, full cash price: approximately $510 per month. No assistance applied.

Patients with no insurance and no savings card should strongly consider the compounded route or the authorized generic with a discount card. The 2020 American Urological Association (AUA) guideline on testosterone deficiency notes that "cost and patient preference should inform the choice of testosterone formulation" 9. That guidance is especially relevant in a state where 8.4% of the population remains uninsured (Kaiser Family Foundation, 2024 estimate).

Clinical Considerations for Arkansas Patients Starting TRT

Before cost enters the conversation, the diagnosis must be correct. The Endocrine Society guideline recommends against prescribing testosterone to men who have not had at least two morning (before 10 AM) serum total testosterone measurements below 300 ng/dL, along with signs or symptoms of androgen deficiency such as decreased libido, erectile dysfunction, fatigue, or loss of muscle mass 2.

The T-Trials demonstrated that testosterone gel applied daily for 12 months improved sexual desire and erectile function (measured by the Psychosexual Daily Questionnaire, P<0.001 vs. placebo), increased 6-minute walk distance by 33 meters in mobility-limited men, and modestly improved depressive symptoms in men with mild depression at baseline 4. These benefits were observed at a mean achieved testosterone level of 500 ng/dL.

Cardiovascular safety data have matured. The TRAVERSE trial (N=5,204, mean follow-up 33 months) found that testosterone replacement did not increase the incidence of major adverse cardiovascular events compared to placebo in men aged 45 to 80 with hypogonadism and established or high risk for cardiovascular disease (hazard ratio 0.99 to 95% CI 0.81 to 1.21) 10. That result, published in the New England Journal of Medicine in 2023, addressed a safety concern that had lingered since the FDA's 2015 label warning.

Monitoring is non-negotiable. Hematocrit should be checked at 3 to 6 months after starting therapy and annually thereafter, with dose reduction or temporary discontinuation if it exceeds 54% 2. PSA should be measured at baseline and at 3 to 12 months. Patients with a PSA rise greater than 1.4 ng/mL within 12 months of starting TRT warrant urologic referral.

The Endocrine Society guideline also states: "We recommend against testosterone therapy in men who are planning fertility in the near term" 2. Exogenous testosterone suppresses gonadotropins and can reduce sperm counts to zero. Arkansas clinicians should counsel younger men on this effect and discuss alternatives such as clomiphene citrate (off-label) or human chorionic gonadotropin (hCG) if fertility preservation is a priority.

How to Transfer an AndroGel Prescription to an Arkansas Pharmacy

If you are relocating to Arkansas or switching pharmacies within the state, the process is straightforward. Call the new Arkansas pharmacy and provide the name and phone number of your current pharmacy. The receiving pharmacist will initiate the transfer. For Schedule III controlled substances like testosterone, federal law permits one transfer per prescription between retail pharmacies, though pharmacies sharing a real-time database (e.g., CVS to CVS) may transfer more freely.

If your prescriber is out of state, they can still write for testosterone gel as long as they hold an active, unrestricted medical license. However, some Arkansas pharmacies may require the prescriber to be licensed in Arkansas for controlled substance prescriptions. Confirm with the specific pharmacy before placing the transfer request.

Patients using telehealth platforms should verify that their provider is licensed in Arkansas. Multi-state telemedicine platforms typically ensure this, but asking the question upfront avoids a rejected prescription at the pharmacy counter.

Baseline lab work ordered by your previous provider is valid for the new prescriber's review, though most clinicians will want to repeat testosterone levels within 90 days of the initial encounter to establish their own baseline.